Wang Chao, Fan Rui-Qin, Zhang Yan-Xiang, Nie Hao, Li Kan
Chao Wang, Yan-Xiang Zhang, Hao Nie, Kan Li, Department of Laboratory Medicine, Medical School, Yangtze University, Jingzhou 434023, Hubei Province, China.
World J Gastroenterol. 2016 Nov 28;22(44):9775-9783. doi: 10.3748/wjg.v22.i44.9775.
To explore the protective effects and mechanisms of naringenin (NRG) on hepatic injury induced by isoniazid (INH) and rifampicin (RIF).
Male mice were randomly divided into four groups and treated for 14 d as follows: normal control group was administered intragastrically with normal saline solution alone; model group was administered intragastrically with INH (100 mg/kg) and RIF (100 mg/kg); low- and high-dosage NRG pretreatment groups were administered intragastrically with different doses of NRG (50 or 100 mg/kg) 2 h before INH and RIF challenge. Mice were killed 16 h after the last dose of drug treatment to determine activity of serum transaminases. Oxidative stress was evaluated by measuring hepatic glutathione (GSH) and superoxide dismutase (SOD) and malondialdehyde (MDA) levels. Histopathological changes in hepatic tissue were observed under the optical microscope. Hepatocyte apoptosis was measured by TUNEL assay and caspase-3 activation. Expression of Bcl-2 and Bax in liver was determined by western blot.
Both low- and high-dosage NRG pretreatment obviously alleviated serum levels of alanine aminotransferase and aspartate aminotransferase, liver index, hepatic MDA content, and increased hepatic GSH content and SOD activity compared with the INH and RIF-treated group (44.71 ± 8.15 U/L, 38.22 ± 6.64 U/L 58.15 ± 10.54 U/L; 98.36 ± 14.78 U/L, 92.41 ± 13.59 U/L 133.05 ± 19.36 U/L; 5.34% ± 0.26%, 4.93% ± 0.25% 5.71% ± 0.28%; 2.76 ± 0.67 nmol/mgprot, 2.64 ± 0.64 nmol/mgprot 4.49 ± 1.12 nmol/mgprot; 5.91 ± 1.31 mg/gprot, 6.42 ± 1.42 mg/gprot 3.11 ± 0.73 mg/gprot; 137.31 ± 24.62 U/mgprot, 148.83 ± 26.75 U/mgprot 102.34 ± 19.22 U/mgprot; all < 0.01 or 0.05). Histopathological evaluation showed obvious necrosis and inflammatory cell infiltration in liver of mice administered INH and RIF; however, mice pretreated with NRG showed minor hepatic injury. In addition, INH and RIF resulted in hepatocyte apoptosis, and NRG pretreatment dramatically suppressed INH- and RIF-induced hepatocytes apoptosis. Furthermore, NRG-mediated anti-apoptotic effects seemed to be in connection with its regulation of Bax and Bcl-2 protein expression in hepatic tissue.
NRG might attenuate INH- and RIF-induced hepatic injury suppression of oxidative stress and hepatocyte apoptosis.
探讨柚皮素(NRG)对异烟肼(INH)和利福平(RIF)所致肝损伤的保护作用及机制。
将雄性小鼠随机分为四组,按如下方式处理14天:正常对照组仅给予生理盐水灌胃;模型组给予INH(100 mg/kg)和RIF(100 mg/kg)灌胃;低剂量和高剂量NRG预处理组在给予INH和RIF攻击前2小时,分别给予不同剂量的NRG(50或100 mg/kg)灌胃。末次给药后16小时处死小鼠,测定血清转氨酶活性。通过测量肝脏谷胱甘肽(GSH)、超氧化物歧化酶(SOD)和丙二醛(MDA)水平评估氧化应激。在光学显微镜下观察肝组织的组织病理学变化。通过TUNEL法和caspase-3活化检测肝细胞凋亡。通过蛋白质印迹法测定肝脏中Bcl-2和Bax的表达。
与INH和RIF处理组相比(44.71±8.15 U/L、38.22±6.64 U/L 58.15±10.54 U/L;98.36±14.78 U/L、92.41±13.59 U/L 133.05±19.36 U/L;5.34%±0.26%、4.93%±0.25% 5.71%±0.28%;2.76±0.67 nmol/mgprot、2.64±0.64 nmol/mgprot 4.49±1.12 nmol/mgprot;5.91±1.31 mg/gprot、6.42±1.42 mg/gprot 3.11±0.73 mg/gprot;137.31±24.62 U/mgprot、148.83±26.75 U/mgprot 102.34±19.22 U/mgprot;均P<0.01或0.05),低剂量和高剂量NRG预处理均明显减轻血清丙氨酸转氨酶和天冬氨酸转氨酶水平、肝脏指数、肝脏MDA含量,并增加肝脏GSH含量和SOD活性。组织病理学评估显示,给予INH和RIF的小鼠肝脏有明显坏死和炎性细胞浸润;然而,经NRG预处理的小鼠肝损伤较轻。此外,INH和RIF导致肝细胞凋亡,而NRG预处理显著抑制INH和RIF诱导的肝细胞凋亡。此外,NRG介导的抗凋亡作用似乎与其对肝组织中Bax和Bcl-2蛋白表达的调节有关。
NRG可能通过抑制氧化应激和肝细胞凋亡减轻INH和RIF所致的肝损伤。